Nymox Pharma files amended annual report on Form 20-F/A for 2025
Nymox Pharmaceutical Corporation published a revised annual report for the year ended Dec. 31, 2025, correcting the date of its independent audit report to Sept. 11, 2026. No other changes were made beyond updated signature, certification and exhibit items.
1. Filing changes
Nymox Pharmaceutical Corporation published a revised annual report for the year ended Dec. 31, 2025. The filing corrected the date of M&K CPAS, PLLC’s independent audit report to Sept. 11, 2026; no other changes were made beyond updated signature, certification and exhibit items.
